David Schnell

Filings by David Schnell span 4 companies, the busiest being Trubion Pharmaceuticals, Inc, Kythera Biopharmaceuticals Inc and Senomyx Inc. The record holds 13 filings, for trades running from 9 February 2006 to 8 April 2019.

Purchases make up the whole of the open-market record (2 purchases, €365k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

On 10 April 2019 came the latest disclosure, a transaction in NGM Biopharmaceuticals Inc. The most recent open-market purchase was published on 19 October 2006, 7,309 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.